Construction of the asset pool of pharmaceutical intellectual property securitization
GUAN Qi-jie
SUN Li-hua
Abstract：The main reason for the rapid loss of pharmaceutical intellectual property rights of Chinese tradi-tional medicine is the serious lack of follow-up R&D funds. The cause of the lack of the funds are the high risk of new drug research, the length of R&D cycle and the domestic single and narrow finacial channel. All of those re-strain the development of our pharmaceutical industry. Now, pharmaceutical intellectual property securitization will resolve the problem. It brings pharmaceutical intellectual property right into capital markets as a kind of assets, so it not only meet the urgent need from researchers but also meet the demands from investors. This article will intro-duce and explore the construction of the asset pool of pharmaceutical intellectual property securitization.
Keywords：pharmaceutical intellectual property rightsecuritizationpatentfinacing legal relationships
Publication Date：2009-01-01
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：5( 2106-2109,2137 )